170 likes | 347 Views
Antiplatelet Therapy. CHAMPION PHOENIX: Primary Efficacy Outcomes at 48 Hours, MITT. TRITON-TIMI 38 13,608 Patients With ACS and Planned PCI Randomized to Prasugrel (60/10) vs Clopidogrel (300/75). TRITON-TIMI 38 Bleeding Events: Safety Cohort (N = 13,457).
E N D
CHAMPION PHOENIX: Primary Efficacy Outcomes at 48 Hours, MITT
TRITON-TIMI 3813,608 Patients With ACS and Planned PCI Randomized to Prasugrel (60/10) vs Clopidogrel (300/75)